OUR PRODUCTS

Cardiac Troponin I (cTnl)

PRODUCT NAME: ST AIA-PACK cTnI 3rd-Gen
INTENDED USE: ST AIA-PACK cTnI 3rd-Gen is designed for IN-VITRO DIAGNOSTIC USE for the quantitative measurement of cardiac troponin I (cTnl) in human serum and heparinized plasma or EDTA plasma on Tosoh AIA immunoassay analyzers.
SUMMARY AND EXPLANATION OF TEST: Troponin I (TnI) has three isoforms: cardiac, fast skeletal and slow skeletal and out of them cardiac troponin I (cTnI) is highly specific to the myocardium. When the myocardium is damaged, cTnI is released into the blood. The level of cTnI becomes abnormally high 3-4 hours after the onset of acute myocardial infarction and reaches the peak 10-16 hours after the onset. The level of cTnI remains abnormally high for 5-8 days after the onset. When compared to Myoglobin or CK-MB, the degree of its change in relation to the cut-off value is much greater for cTnI (undetectable in healthy individuals) and as a result, it is possible to detect minute myocardial lesions. In addition, increased cTnI levels in heart failure patients indicates latent cardiomyopathy.
TECHNICAL SPECIFICATIONS:
Method: Enzyme Immunoassay (EIA)
Principle: Two-site immunoenzymometric assay
Calibrators: 0, 0.2, 1.0, 5.0, 20, 60 ng/mL
Assay sample: Serum and heparinized plasma, EDTA plasma
Assay range: 0.03 - 50 ng/mL
Storage: 2 - 8 ºC
Kit Contents: ST AIA-PACK cTnI 3rd-Gen
Consumables: AIA-PACK SUBSTRATE SET II
AIA-PACK cTnI 3rd-Gen CALIBRATOR SET
AIA-PACK cTnI 3rd-Gen SAMPLE DILUTING SOLUTION
AIA-PACK WASH CONCENTRATE
AIA-PACK DILUENT CONCENTRATE
AIA-PACK DETECTOR STANDARDIZATION TEST CUP
AIA-PACK SAMPLE TREATMENT CUP
SAMPLE CUPS

*Please refer to the product Instruction-For-Use (IFU) for complete details.

0.2 - 200 mIU/mL